Cassava Sciences Inc (SAVA)
2.34
-0.07
(-2.90%)
USD |
NASDAQ |
Dec 24, 16:00
Cassava Sciences Free Cash Flow: -78.07M for Sept. 30, 2024
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Bristol-Myers Squibb Co | 13.80B |
| BridgeBio Pharma Inc | -456.32M |
| Seelos Therapeutics Inc | -13.27M |
| Alnylam Pharmaceuticals Inc | 16.06M |
| EyePoint Pharmaceuticals Inc | -118.04M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -18.30M |
| Cash from Investing (Quarterly) | -0.017M |
| Free Cash Flow Per Share (Quarterly) | -0.3817 |
| Free Cash Flow Yield | -73.94% |